Search Within

Neerav Shukla

Formats
  1. Journal Article (76)
  2. Meeting Abstract (74)
  3. Review (5)
  4. Research Letter (3)
  5. Editorial (2)
Groups
  1. Center for Hematologic Malignancies (160)
  2. Hematologic Malignancies Service (160)
  3. Pediatric Leukemia (160)
  4. Pediatrics, Department of (160)
  5. GSK Faculty (87)
  6. Tow Center for Developmental Oncology (TCDO) (82)

More Groups

People
  1. Marc Ladanyi (41)
  2. Peter Steinherz (36)
  3. Rachel Kobos (31)
  4. Andrew Kung (26)
  5. Michael Berger (21)
  6. Michael Walsh (19)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (14)
  5. 2021 (12)
  6. 2020 (11)

More Years

Publications
  1. Blood (27)
  2. Pediatric Blood and Cancer (20)
  3. Journal of Clinical Oncology (16)
  4. JCO Precision Oncology (8)
  5. Cancer Research (7)
  6. Clinical Cancer Research (7)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. American Society of Clinical Oncology (24)
  3. Wiley Periodicals, Inc (20)
  4. American Association for Cancer Research (17)
  5. Nature Publishing Group (12)
  6. Oxford University Press (10)

More Publishers

Results (160)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of a TP53 deletion in an undifferentiated embryonal sarcoma of the liver provides clinically relevant longitudinal detection of circulating tumor DNA
    Journal Article

    Kothari, P.; Sauerhaft, T.; Bouvier, N.; Rodriguez-Sanchez, M. I.; Shia, J.; Price, A.; Morjaria, S.; Gerstle, J. T.; Shukla, N. N.; Ortiz, M. V.
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Prospects for epigenetic targeted therapies of bone and soft-tissue sarcomas
    Review

    Wang, J.; Elkrief, A.; Guo, W.; Shukla, N.; Gounder, M.; Ladanyi, M.
    Sarcoma (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling of desmoplastic small round cell tumor
    Journal Article

    Slotkin, E. K.; Bowman, A. S.; Levine, M. F.; Dela Cruz, F.; Coutinho, D. F.; Sanchez, G. I.; Rosales, N.; Modak, S.; Tap, W. D.; Gounder, M. M.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Matched targeted therapy for pediatric patients with relapsed, refractory, or high-risk leukemias: A report from the LEAP Consortium
    Journal Article

    Pikman, Y.; Tasian, S. K.; Sulis, M. L.; Stevenson, K.; Blonquist, T. M.; Apsel Winger, B.; Cooper, T. M.; Pauly, M.; Maloney, K. W.; Burke, M. J.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: An entity distinct from JMML
    Journal Article

    Spitzer, B.; Dela Cruz, F. S.; Ibanez Sanchez, G. D.; Zhang, Y.; Xiao, W.; Benayed, R.; Markova, A.; Rodriguez-Sanchez, M. I.; Bouvier, N.; Roshal, M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Blinatumomab for treatment of children with high-risk relapsed B-cell acute lymphoblastic leukemia
    Editorial

    Shukla, N.; Sulis, M. L.
    JAMA - Journal of the American Medical Association (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin plus bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma: A multi-institution retrospective analysis
    Meeting Abstract

    Forlenza, C. J.; Gulati, N.; Mauguen, A.; Absalon, M. J.; Castellino, S. M.; Franklin, A.; Keller, F. G.; Shukla, N.
    Blood (2020)

    Fulltext@MSK | Save
  • Phase 1 study of tazemetostat, an enhancer of zeste homolog-2 (EZH2) inhibitor, in pediatric patients with relapsed/refractory integrase interactor 1 (INI1)-negative tumors
    Meeting Abstract

    Chi, S.; Bourdeaut, F.; Laetsch, T.; Fouladi, M.; Macy, M.; Makin, G.; Shukla, N.; Wetmore, C.; Margol, A.; Casanova, M.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Larotrectinib demonstrates durable efficacy and safety in an expanded dataset of pediatric patients with TRK fusion cancer
    Meeting Abstract

    Mascarenhas, L.; Albert, C.; Pappo, A.; Geoerger, B.; Doz, F.; Federman, N.; Nagasubramanian, R.; Bielack, S.; Dubois, S.; Morgenstern, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save